Marya Lieberman

Nancy Dee Collegiate Professor of Cancer Research

Office
210 Stepan Chemistry
Notre Dame, IN 46556
Phone
+1 574-631-4665
Email
mlieberm@nd.edu

Lab Website

Research Areas

  • Physical/Analytical Chemistry

Research Specialties

  • Materials
  • Measurement
  • Medicine

Prospective Graduate Students

Request More Information
Apply

Biography

Year Title
2025-present Nancy Dee Collegiate Professor of Cancer Research, University of Notre Dame
2016-2025 Professor, University of Notre Dame
2002-2016 Associate Professor, University of Notre Dame
1996-2002 Assistant Professor, University of Notre Dame
1994-1996 Postdoctoral Fellow, California Institute of Technology
1994 Ph.D. in Chemistry, University of Washington
1989 B.S. in Chemistry, Massachusetts Institute of Technology

Selected Awards

2026   Father James L. Shilts, C.S.C./Doris & Gene Leonard Teaching Award

2025   Gustavus John Esselen Award for Chemistry in the Public Interest

2022   J. Calvin Giddings Award for Excellence in Education

2022   James A. Burns, C.S.C., Award

2020   Reinhold Niebuhr Award

2019   Eminent Scientist Lecturer, American Chemical Society

2015   Partners for Progress Prosperity (P3) Award, ACS Joint Great Lakes/Central Region

2010   Joyce Award for Excellence in Undergraduate Teaching

2010-2011   Kaneb Faculty Fellow

2001-present   Reilly Fellow

1998   NSF Career Award

1994-1996   NSF Postdoctoral Fellowship

Research Interests

Paper Analytical Devices

My lab designs paper analytical devices (PADs) to solve a host of analytical problems in low resource settings. We create millifluidic structures such as solution channels, reagent storage areas, and mixing zones on paper or nitrocellulose, and we develop chemical color reactions that work in mild conditions. This enables us to automate operations that would normally be carried out with glassware in a lab setting. Some ongoing technical goals are improving quantification of the target analytes, broadening the targets to include “biological” drugs, integrating PADs with vibrational spectroscopy and LCMS, and manufacturability/commercialization. User-centered design and field testing are integral to our projects, and researchers in my group currently do part of their work in community settings in the US and in Kenya, Malawi, Ethiopia, or Cameroon. Tracking and analysis of large sample sets is also a common feature of these projects, and most researchers in the group learn to use R, Matlab, or Python to analyze spectra, sample metadata, or PAD images. Our PADs have been trialed in Bangladesh, Britain, Burkina Faso, Cameroon, Ethiopia, Ghana, India, Israel, Kenya, Laos, Liberia, Malawi, Palestine, the Philippines, South Africa, Sudan, Tanzania, Uganda, and the US, and by organizations such as Medecins Sans Frontieres, SIDAI, and the US Pharmacopia.

Two current areas of focus are chemotherapy drug quality and opioid harm reduction.

1) In many low- and middle-income countries, chemotherapy drugs are becoming more available, but the outcomes for patients are much worse than in high-income countries. There are increasing concerns that poor quality chemo drugs are responsible for many of these bad outcomes. My group developed chemoPADs to screen the quality of chemo drugs at the point of care, before they are administered to patients; this project involves collaborators from UND and four countries in sub-Saharan Africa.

2) In the US, the unregulated supply of illicit street drugs is associated with over 100,000 overdose deaths per year. My lab is DEA registered to conduct research on controlled substances such as fentanyl, xylazine, and other overdose hazards. We work with harm reduction organizations in multiple states to monitor the components of street drugs, detect emerging highly potent opioids, and check the quality of immunoassay test strips used to detect overdose hazards.

Selected Publications

  • Joseph, O.; Jandev, V.; Zhang, Z. T.; Kwon, D.; Cho, B.; Sammanasu, D.; Wicks, A. and Lieberman, M. "Adhesive Tape for Spatially Resolved and Sensitive Detection of Lead in Dust using XRF" 2026 Analytical Methods, 18 (6), pp. 1201-1208. DOI: 10.1039/d5ay01275a.
  • Higgins, C. R.; Wilfinger, M. J.; Doohan, J.; Okorigwe, E.; Ashenef, A.; Fentie, A. M.; Chikowe, I.; Kumwenda, H. S.; Ndom, P.; Saidu, Y.; Opakas, J.; Pastakia, S.; Were, P. M.; Muluneh, B.; Lieberman, M. and Ozawa, S. "Chemotherapy Medications in Sub-Saharan Africa: Availability, Pricing, Affordability, and Predictors of Quality" 2026 JCO Global Oncology, 12, e2500118. DOI: 10.1200/GO-25-00118.
  • Saidu, Y.; Makia, M. C.; Frambo, A.; Nang, A. N.; Mulu, A.; Ashenef, A.; Benyam, M.; Chikowe, I.; Pastakia, S. D.; Higgins, C. R.; Paul, N. and Lieberman, M. "Barriers to Accessing High-Quality Cancer Medicines in Cameroon. A Qualitative Study of the Views and Practices of Regulators and Frontline Healthcare Providers" 2026 PLOS Global Public Health, 6 (1), e0005370. DOI: 10.1371/journal.pgph.0005370.
  • Amate, A. and Lieberman, M. "Chiral Sensitivity of Medetomidine Lateral Flow Immunoassay Test Strips" 2026 Harm Reduction Journal, 23 (1), 19. DOI: 10.1186/s12954-025-01387-6.
  • El Azar, C. G.; Amate, A. and Lieberman, M. "Performance of Fentanyl Test Wipes Based on Eosin Y Dye" 2025 Forensic Chemistry, 46, 100713. DOI: 10.1016/j.forc.2025.100713.
  • Pathak, N.; Lieberman, M.; Frederick, K. A. and Clark, G. A. "A Low-Tech Laboratory Exercise to Explore Electrochemistry, Binding Coefficients and Batteries" 2025 Journal of Chemical Education, 102 (11), pp.4878–4883. DOI: 10.1021/acs.jchemed.5c00543.